KR950000882A - Nucleotide and Amino Acid Sequences of the Hypervariable Region of Korean Hepatitis C Virus - Google Patents

Nucleotide and Amino Acid Sequences of the Hypervariable Region of Korean Hepatitis C Virus Download PDF

Info

Publication number
KR950000882A
KR950000882A KR1019930009915A KR930009915A KR950000882A KR 950000882 A KR950000882 A KR 950000882A KR 1019930009915 A KR1019930009915 A KR 1019930009915A KR 930009915 A KR930009915 A KR 930009915A KR 950000882 A KR950000882 A KR 950000882A
Authority
KR
South Korea
Prior art keywords
amino acid
polypeptide
threonine
alanine
acid sequence
Prior art date
Application number
KR1019930009915A
Other languages
Korean (ko)
Other versions
KR100301795B1 (en
Inventor
조중명
박영우
Original Assignee
최근선
주식회사 럭키
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 최근선, 주식회사 럭키 filed Critical 최근선
Priority to KR1019930009915A priority Critical patent/KR100301795B1/en
Publication of KR950000882A publication Critical patent/KR950000882A/en
Application granted granted Critical
Publication of KR100301795B1 publication Critical patent/KR100301795B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24251Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

본 발명은 한국형 C형 간염 바어러스의 E2/NS1 단백질 아미노산 서열의 초변화 영역의 전부 또는 일부를 포함하는 폴리펩티드 및 그를 코오드화하는 뉴클레오티드 서열, 상기 뉴클레오티드 서열을 갖는 cDNA 또는 그 절편을 포함하는 발현백터, 상기 발현백터로 형질전환된 미생물 및 상기 미생물을 배양하여 한국형 C형 간염 바이러스의 E2/NS1 단백질 아미노산 서열의 초변화 영역의 전부 또는 일부를 포함하는 폴리펩티드를 생산하는 방법에 관한 것이다.The present invention provides a polypeptide comprising all or a portion of the hypervariable region of the E2 / NS1 protein amino acid sequence of the Korean hepatitis C virus, the nucleotide sequence encoding the same, an expression vector comprising the cDNA having the nucleotide sequence or fragments thereof. The present invention relates to a method for producing a polypeptide comprising all or part of a hypervariable region of the E2 / NS1 protein amino acid sequence of the Korean hepatitis C virus by culturing the microorganism transformed with the expression vector and the microorganism.

Description

한국형 씨(C)형 간염 바이러스의 초변화 영역의 뉴클레오티드 서열 및 아미노산 서열.Nucleotide and Amino Acid Sequences of the Hyperchange Region of Korean Hepatitis C Virus.

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

제1도는 단편 HV-A의 뉴클레오티드 서열 및 이로부터 유추된 아미노산 서열을 나타낸 것이다.Figure 1 shows the nucleotide sequence of fragment HV-A and the amino acid sequence inferred therefrom.

Claims (30)

한국형 C형 간염 바이러스의 E2/NS1 단백질 아미노산 서열의 초변화 영역인 384번 내지 410번 아미노산(C형 간염 바이러스 유전자에 코오드화된 전체 아미노산 서열 기준) 서열의 전부 또는 일부를 포함하는 폴리펩티드.A polypeptide comprising all or a portion of amino acids 384 to 410 (based on the entire amino acid sequence encoded in the hepatitis C virus gene) sequence, which is a hypervariable region of the E2 / NS1 protein amino acid sequence of the Korean hepatitis C virus. 제1항에 있어서, 385번째의 아미노산이 트레오닌, 386번째의 아미노산이 아르기닌 또는 히스티딘, 387번째의 아미노산이 트레오닌 또는 발린, 388번째의 아미노산이 트레오닌 또는 발린, 389번째의 아미노산이 글리신, 390번째의 아미노산이 글리신, 391번째의 아미노산이 트레오닌, 세린 또는 알라닌, 392번째의 아미노산이 알라닌, 393번째의 아미노산이 알라닌 또는 글리신, 394번째의 아미노산이 아르기닌 또는 히스티딘, 395번째의 아미노산이 트레오닌, 세린 또는 알라닌, 396번째의 아미노산이 트레오닌 또는 알라닌, 397번째의 아미노산이 세린, 아르기닌, 라이신 또는 히스티딘, 398번째의 아미노산이 글리신, 트레오닌 또는 세린, 399번째의 아미노산이 루이신 또는 페닐알라닌, 400번째의 아미노산이 트레오닌 또는 알라닌, 401번째의 아미노산이 세린, 402번째의 아미노산이 루이신, 403번째의 아미노산이 페닐알라닌, 404번째의 아미노산이 트레오닌 또는 세린, 406번째의 아미노산이 글리신, 407번째의 아미노산이 프롤린 또는 알라닌, 408번째의 아미노산이 알라닌, 세린 또는 글루타민, 409번째의 아미노산이 글루타민, 410번째의 아미노산이 라이신, 아르기닌 또는 아스파라긴으로 구성된 폴리펩티드.The 385th amino acid is threonine, the 386th amino acid is arginine or histidine, the 387th amino acid is threonine or valine, the 388th amino acid is threonine or valine, the 388th amino acid is glycine, the 390th amino acid is glycine Amino acid is glycine, 391 amino acid is threonine, serine or alanine, 392 amino acid is alanine, 393 amino acid is alanine or glycine, 394 amino acid is arginine or histidine, 395 amino acid is threonine, serine or alanine , 396th amino acid threonine or alanine, 397th amino acid serine, arginine, lysine or histidine, 398th amino acid glycine, threonine or serine, 399th amino acid leucine or phenylalanine, 400th amino acid threonine Or alanine, the 401th amino acid serine, the 402th The amino acid is leucine, the 403th amino acid is phenylalanine, the 404th amino acid is threonine or serine, the 406th amino acid is glycine, the 407th amino acid is proline or alanine, the 408th amino acid is alanine, serine or glutamine, the 409th The polypeptide of which amino acid is glutamine, and the 410th amino acid consists of lysine, arginine, or asparagine. 제2항에 있어서, 하기 아미노산 서열을 갖는 폴리펩티드.The polypeptide of claim 2 having the following amino acid sequence. A K V L I V M L L F A G V D G T T Y T TA K V L I V M L L F A G V D G T T Y T T G G T T G R T T G G L T S L F T S G A SG G T T G R T T G G L T S L F T S G A S Q K V Q L V N T N G S W H I N R T A L NQ K V Q L V N T N G S W H I N R T A L N C N D S L Q T G F L A A L F Y T H R F NC N D S L Q T G F L A A L F Y T H R F N S S G C Q RS S G C Q R 제2항에 있어서, 하기 아미노산 서열을 갖는 폴리펩티드.The polypeptide of claim 2 having the following amino acid sequence. N W S P T A A L V M S Q L L R I P Q T VN W S P T A A L V M S Q L L R I P Q T V L D V V A G A H W G V L A G L A Y Y S ML D V V A G A H W G V L A G L A Y Y S M A G N W A K V L I V L L L F A G V D G GA G N W A K V L I V L L L F A G V D G G E A W R T R T I G G K Q P Q G V S T I TE A W R T R T I G G K Q P Q G V S T I T S L F S S G P A Q K I Q L V N T N G S WS L F S S G P A Q K I Q L V N T N G S W H I N R T A L N C N D S F Q T G F L A AH I N R T A L N C N D S F Q T G F L A A L F Y V R N F N A S G C P E R M A S C RL F Y V R N F N A S G C P E R M A S C R P I D T F N Q G W G P I T Y T R P D S PP I D T F N Q G W G P I T Y T R P D S P D Q R P Y C W H Y PD Q R P Y C W H Y P 제2항에 있어서, 하기 아미노산 서열을 갖는 폴리펩티드.The polypeptide of claim 2 having the following amino acid sequence. M V G N W A K V L I V M L L F A G V D GM V G N W A K V L I V M L L F A G V D G T T V T M G G T V A R T T T G F T G L FT T V T M G G T V A R T T T G F T G L F R P G A S Q K I Q L I N T N G S W H I NR P G A S Q K I Q L I N T N G S W H I N R T A L N C N D F L N T G F L A A L F YR T A L N C N D F L N T G F L A A L F Y T H R F N A S G C P E R M A S C Q S I DT H R F N A S G C P E R M A S C Q S I D R F I Q G W G P I T Y A E N G S S D Q RR F I Q G W G P I T Y A E N G S S D Q R R Y C W H Y P PR Y C W H Y P P 제2항에 있어서, 하기 아미노산 서열을 갖는 폴리펩티드.The polypeptide of claim 2 having the following amino acid sequence. A K V L I V M L L F A G V D G E T H V TA K V L I V M L L F A G V D G E T H V T G G S V A G Y T S G L T S L F T L G P AG G S V A G Y T S G L T S L F T L G P A Q K I Q L V N T N G S W H I N R T A L NQ K I Q L V N T N G S W H I N R T A L N C N D S L H T G F L A G L F Y H H R F NC N D S L H T G F L A G L F Y H H R F N A S G C P A R M A S C R P I D K F D Q GA S G C P A R M A S C R P I D K F D Q G W G P I T Y A K Q G S Q D Q R P Y C W HW G P I T Y A K Q G S Q D Q R P Y C W H 제2항에 있어서, 하기 아미노산 서열을 갖는 폴리펩티드.The polypeptide of claim 2 having the following amino acid sequence. G S S S C D T T R A V V G D Q F I I I SG S S S C D T T R A V V G D Q F I I I S Q A M R I P Q A I V D M V A G A H W G VQ A M R I P Q A I V D M V A G A H W G V L A G L A Y Y S M V G N W A K V L I V ML A G L A Y Y S M V G N W A K V L I V M L L F A G V D G T A R T T G G A A V P SL L F A G V D G T A R T T G G A A V P S T S G V A S L F I S G P A Q R I Q L I NT S G V A S L F I S G P A Q R I Q L I N T N G S W H I N R T A L N C N D S L Q AT N G S W H I N R T A L N C N D S L Q A G F L A A L F Y A H K F N A S G C P E RG F L A A L F Y A H K F N A S G C P E R M A S C R S I D A F D Q G W G P I T Y TM A S C R S I D A F D Q G W G P I T Y T 제2항에 있어서, 하기 아미노산 서열을 갖는 폴리펩티드.The polypeptide of claim 2 having the following amino acid sequence. A K V L I V M L L F A G V D G R A R T VA K V L I V M L L F A G V D G R A R T V G G T A A R D T S G F A S L F T A G P AG G T A A R D T S G F A S L F T A G P A Q K I Q L V N T N G S W H I N R T A L NQ K I Q L V N T N G S W H I N R T A L N C N D S L Q T G F L A A L F Y T R N F NC N D S L Q T G F L A A L F Y T R N F N A S G C L E R M A S C R P I G A F D Q GA S G C L E R M A S C R P I G A F D Q G W G P I T Y A E R R G S D Q R P Y C W HW G P I T Y A E R R G S D Q R P Y C W H Y PY P 제2항에 있어서, 하기 아미노산 서열을 갖는 폴리펩티드.The polypeptide of claim 2 having the following amino acid sequence. N W S P T T A L V V S Q L L R I P R A IN W S P T T A L V V S Q L L R I P R A I M D V V A G A H W G V L A G L A Y Y S MM D V V A G A H W G V L A G L A Y Y S M V G N W A K V L I V M L L F A G V D G GV G N W A K V L I V M L L F A G V D G G T Y T T G G T Q A R A A H G F T S L L ST Y T T G G T Q A R A A H G F T S L L S L G A S Q K V Q L I N T N G S W H I N RL G A S Q K V Q L I N T N G S W H I N R T A L N C N E S L Q T G W L A A L F Y TT A L N C N E S L Q T G W L A A L F Y T H K F N A S G C P E R M A R S A A I D TH K F N A S G C P E R M A R S A A I D T F N Q G W G P V T Y T E P G S R D Q K PF N Q G W G P V T Y T E P G S R D Q K P Y C R H Y A P R Q C G I A P A S E V C VY C R H Y A P R Q C G I A P A S E V C V Q S TQ S T 제2항에 있어서, 하기 아미노산 서열을 갖는 폴리펩티드.The polypeptide of claim 2 having the following amino acid sequence. N W S P T T T I I L A Y V M R V P E V IN W S P T T T I I L A Y V M R V P E V I I D I I S G A H W G V M F G L A Y F S MI D I I S G A H W G V M F G L A Y F S M Q G A W A K V V V I L L L A A G V D A RQ G A W A K V V V I L L L A A G V D A R T H T S G G S V A R A T Y G L T S W F ST H T S G G S V A R A T Y G L T S W F S P G A R K C Q L I N T N G S W H I N R TP G A R K C Q L I N T N G S W H I N R T A L N C N D S L H T G F I A S FA L N C N D S L H T G F I A S F 제2항에 있어서, 하기 아미노산 서열을 갖는 폴리펩티드.The polypeptide of claim 2 having the following amino acid sequence. N W S P T T A L V V S Q L L R I P Q A IN W S P T T A L V V S Q L L R I P Q A I M D M M A G A H W G V L A G L A Y Y S MM D M M A G A H W G V L A G L A Y Y S M V G N W A K V L I V M L L F A G V D G AV G N W A K V L I V M L L F A G V D G A T Y T T G G A Q A A H G L T S L L ST Y T T G G A Q A A H G L T S L L S R G A S Q R V Q L I N T N G S W H I N RR G A S Q R V Q L I N T N G S W H I N R T A L N C N E S L Q T G W L A A L F Y TT A L N C N E S L Q T G W L A A L F Y T F D Q G W R P I T Y T E P G D L D Q R SF D Q G W R P I T Y T E P G D L D Q R S Y C W H T A P R Q C S I V P A S Y VY C W H T A P R Q C S I V P A S Y V 제2항에 있어서, 하기 아미노산 서열을 갖는 폴리펩티드.The polypeptide of claim 2 having the following amino acid sequence. N W S P T S T M I L A Y V M R V P E V IN W S P T S T M I L A Y V M R V P E V I I D I I S G A H W G V M F G L A Y F S MI D I I S G A H W G V M F G L A Y F S M Q G A W A K V V V I K K K A A G V D A SQ G A W A K V V V I K K K A A G V D A S T H T T G G S A T Y T T S S L A K M F ST H T T G G S A T Y T T S S L A K M F S F G S N Q N I Q L I N T N G S W HF G S N Q N I Q L I N T N G S W H 제2항에 있어서, 하기 아미노산 서열을 갖는 폴리펩티드.The polypeptide of claim 2 having the following amino acid sequence. N W S P T T A L V V S Q L L R I P Q A VN W S P T T A L V V S Q L L R I P Q A V L D M V A G A H W G V L A G L A Y Y S ML D M V A G A H W G V L A G L A Y Y S M V G N W A K V L I V M L L F A S V D G SV G N W A K V L I V M L L F A S V D G S T R V T G G R H A H T T K S L A S L F ST R V T G G R H A H T T K S L A S L F S S G P S Q K I Q L V N T N G S W H I N RS G P S Q K I Q L V N T N G S W H I N R T A L N C N D S L Q T G FT A L N C N D S L Q T G F 제2항에 있어서, 하기 아미노산 서열을 갖는 폴리펩티드.The polypeptide of claim 2 having the following amino acid sequence. N W S P T A T M I L A Y A M R V P E V IN W S P T A T M I L A Y A M R V P E V I I D I I S G A H W G V M F G L A Y F S MI D I I S G A H W G V M F G L A Y F S M Q G A W A K V V V I L L L T A G V D A NQ G A W A K V V V I L L L T A G V D A N T H M V G G S A A R S T R G F T S L F ST H M V G G S A A R S T R G F T S L F S S G P Q R N I Q L I N T N G S W H I N RS G P Q R N I Q L I N T N G S W H I N R T A L N C N E ST A L N C N E S 제2항에 있어서, 하기 아미노산 서열을 갖는 폴리펩티드.The polypeptide of claim 2 having the following amino acid sequence. N W S P T A T M I L A Y A M R V P E V IN W S P T A T M I L A Y A M R V P E V I I D I I S G A H W G V M F G L A Y F F MI D I I S G A H W G V M F G L A Y F F M Q G A W A K V V V I L L L T A G V D A DQ G A W A K V V V I L L L T A G V D A D T H A V G G A A A R S A Y R L T S F F ST H A V G G A A A R S A Y R L T S F F S L G P Q Q N I Q L I N T N G S W H I N RL G P Q Q N I Q L I N T N G S W H I N R T A L N C N D S L N TT A L N C N D S L N T 제2항에 있어서, 하기 아미노산 서열을 갖는 폴리펩티드.The polypeptide of claim 2 having the following amino acid sequence. N W S P T A T M I L A Y S M R I P E V IN W S P T A T M I L A Y S M R I P E V I I D I I S G A H W G V M F G L A Y F S MI D I I S G A H W G V M F G L A Y F S M Q G A W A K V A V I L L L A A G V D A HQ G A W A K V A V I L L L A A G V D A H T H V A G G T A A F N A H G L A S L F TT H V A G G T A A F N A H G L A S L F T R G A Q Q K T Q L I N T N G S W H V N RR G A Q Q K T Q L I N T N G S W H V N R T A L N C N D S L R T G F I AT A L N C N D S L R T G F I A 제2항에 있어서, 하기 아미노산 서열을 갖는 폴리펩티드.The polypeptide of claim 2 having the following amino acid sequence. N W S P T A A L V V S Q L L R I P Q A VN W S P T A A L V V S Q L L R I P Q A V M D M L A G A H W G V L A G L A Y Y S MM D M L A G A H W G V L A G L A Y Y S M V G N W A K V L I V M L L F A G V D G EV G N W A K V L I V M L L F A G V D G E T R V T G G R A G Q T T R S L T S L F ST R V T G G R A G Q T T R S L T S L F S T G P Q Q K I Q L I N T N G S W H I N ST G P Q Q K I Q L I N T N G S W H I N S T A L D C N D S L Q T G F L A A R F YT A L D C N D S L Q T G F L A A R F Y 제2항에 있어서, 하기 아미노산 서열을 갖는 폴리펩티드.The polypeptide of claim 2 having the following amino acid sequence. N W S P T T A L V V S Q L L R I P Q A VN W S P T T A L V V S Q L L R I P Q A V V K N V T G S H W G I L A G L A Y Y S MV K N V T G S H W G I L A G L A Y Y S M V G N W A K V L I V M L L F A G V D G TV G N W A K V L I V M L L F A G V D G T A Y E D T T P S H Q G G R P A A L Q V HA Y E D T T P S H Q G G R P A A L Q V H V L F D L G P S Q K V Q L I N T N G S RV L F D L G P S Q K V Q L I N T N G S R H I N R T A L N C N D S L N T G F I A SH I N R T A L N C N D S L N T G F I A S L F S T Y R F N A S G C P A R L A S C DL F S T Y R F N A S G C P A R L A S C D P I E T V A Q G W G P I T Y G E P A D SP I E T V A Q G W G P I T Y G E P A D S D Q R P Y C W H Y A P R Q C G I V P A SD Q R P Y C W H Y A P R Q C G I V P A S E V C G PE V C G P 제2항에 있어서, 하기 아미노산 서열을 갖는 폴리펩티드.The polypeptide of claim 2 having the following amino acid sequence. N W S P T A A L M V S Q L L R I P Q A IN W S P T A A L M V S Q L L R I P Q A I V D M V A G A H W G V L A G L A Y Y S MV D M V A G A H W G V L A G L A Y Y S M V G N W A K V L I V M L L F A G V D G TV G N W A K V L I V M L L F A G V D G T T H T T G G S V A R S T S K L T C L F ST H T T G G S V A R S T S K L T C L F S A G S A Q N I Q L MA G S A Q N I Q L M 제2항에 있어서, 하기 아미노산 서열을 갖는 폴리펩티드.The polypeptide of claim 2 having the following amino acid sequence. L V A G A H W R V L A G L A Y Y S M M GL V A G A H W R V L A G L A Y Y S M M G N M A K V L I V M L L F A G V D G E T HN M A K V L I V M L L F A G V D G E T H T T G G A A A H S T R T L T S L F T S GT T G G A A A H S T R T L T S L F T S G P A Q R I Q L I N T N G S L H I N R T AP A Q R I Q L I N T N G S L H I N R T A L N C N D T L Q T G F F A A L F YL N C N D T L Q T G F F A A L F Y 제2항에 있어서, 하기 아미노산 서열을 갖는 폴리펩티드.The polypeptide of claim 2 having the following amino acid sequence. N W D P T A T M I L A Y A M R V P E V IN W D P T A T M I L A Y A M R V P E V I I D I I S G A H W G V T F G L A Y F S MI D I I S G A H W G V T F G L A Y F S M Q G A W A K V V V I L V L A A G V D A GQ G A W A K V V V I L V L A A G V D A G T H T V G G Q A A H S V Y R F T G L F TT H T V G G Q A A H S V Y R F T G L F T R G A K T N I Q L V S SR G A K T N I Q L V S S 제2항에 있어서, 하기 아미노산 서열을 갖는 폴리펩티드.The polypeptide of claim 2 having the following amino acid sequence. N W S P T A T M I L A Y V M R A P E V IN W S P T A T M I L A Y V M R A P E V I I D I V S G A H W G V M F G L A Y F S MI D I V S G A H W G V M F G L A Y F S M Q G A W A K V V V I L L L T A G V D A QQ G A W A K V V V I L L L T A G V D A Q P R I T A Q A A H A T S G L A N L F TP R I T A Q A A H A T S G L A N L F T P G S Q Q N I Q L I S T N G S WP G S Q Q N I Q L I S T N G S W 제2항에 있어서, 하기 아미노산 서열을 갖는 폴리펩티드.The polypeptide of claim 2 having the following amino acid sequence. N W S P T A A L V V S Q L L R I P Q A VN W S P T A A L V V S Q L L R I P Q A V M D V I A G A H W G I L A G L A Y Y S MM D V I A G A H W G I L A G L A Y Y S M V G N W A K V L I V M L L F A G V D G HV G N W A K V L I V M L L F A G V D G H T R V T R G V Q G R T T A G L T S L F ST R V T R G V Q G R T T A G L T S L F S P G P A Q N I Q LP G P A Q N I Q L 제1항의 폴리펩티드를 코오드화하는 염기서열을 포함하는 DNA.DNA comprising a base sequence for coding the polypeptide of claim 1. 제24항에 있어서, 385번째의 아미노산이 트레오닌, 386번째의 아미노산이 아르기닌 또는 히스티딘, 387번째의 아미노산이 트레오닌 또는 발린, 388번째의 아미노산이 트레오닌 또는 발린, 389번째의 아미노산이 글리신, 390번째의 아미노산이 글리신, 391번째의 아미노산이 트레오닌, 세린 또는 알라닌, 392번째의 아미노산이 알라닌, 393번째의 아미노산이 알라닌 또는 글리신, 394번째의 아미노산이 아르기닌 또는 히스티딘, 395번째의 아미노산이 트레오닌, 세린 또는 알라닌, 396번째의 아미노산이 트레오닌 또는 알라닌, 397번째의 아미노산이 세린, 아르기닌, 라이신 또는 히스티딘, 398번째의 아미노산이 글리신, 트레오닌 또는 세린, 399번째의 아미노산이 루이신 또는 페닐알라닌, 400번째의 아미노산이 트레오닌 또는 알라닌, 401번째의 아미노산이 세린, 402번째의 아미노산이 루이신, 403번째의 아미노산이 페닐알라닌, 404번째의 아미노산이 트레오닌 또는 세린, 406번째의 아미노산이 글리신, 407번째의 아미노산이 프롤린 또는 알라닌, 408번째의 아미노산이 알라닌, 세린 또는 글루타민, 409번째의 아미노산이 글루타민, 410번째의 아미노산이 라이신, 아르기닌 또는 아스파라긴으로 구성된 폴리펩티드를 코오드화하는 뉴클레오티드 서열을 포함하는 DNA.The 385th amino acid is threonine, the 386th amino acid is arginine or histidine, the 387th amino acid is threonine or valine, the 388th amino acid is threonine or valine, the 388th amino acid is glycine, and the 390th amino acid is glycine, Amino acid is glycine, 391 amino acid is threonine, serine or alanine, 392 amino acid is alanine, 393 amino acid is alanine or glycine, 394 amino acid is arginine or histidine, 395 amino acid is threonine, serine or alanine , 396th amino acid threonine or alanine, 397th amino acid serine, arginine, lysine or histidine, 398th amino acid glycine, threonine or serine, 399th amino acid leucine or phenylalanine, 400th amino acid threonine Or alanine, 401 th amino acid serine, 402 th The amino acid is leucine, the 403th amino acid is phenylalanine, the 404th amino acid is threonine or serine, the 406th amino acid is glycine, the 407th amino acid is proline or alanine, the 408th amino acid is alanine, serine or glutamine, the 409th A DNA containing a nucleotide sequence which encodes the polypeptide whose amino acid is a glutamine, and the 410th amino acid consists of lysine, arginine, or asparagine. 제25항에 있어서, 제3항 내지 제23항중 어느 한 항의 폴리펩티드를 코오드화하는 뉴클레오티드 서열을 포함하는 DNA.The DNA of claim 25 comprising a nucleotide sequence encoding a polypeptide of any one of claims 3-23. 제26항에 있어서, 제1도 내지 제21도의 뉴클레오티드 서열중 어느 하나를 포함하는 DNA.The DNA of claim 26 comprising any of the nucleotide sequences of FIGS. 1-21. 제1도 내지 제21도의 뉴클레오티드 서열중 어느 하나를 갖는 한국형 C형 간염 바이러스 cDNA 또는 그 절편을 포함하는 발현벡터.An expression vector comprising a Korean-type hepatitis C virus cDNA or fragment thereof having any one of the nucleotide sequences of FIGS. 1 to 21. 제28항의 벡터에 의해 형질전환된 미생물.A microorganism transformed with the vector of claim 28. 제29항의 미생물을 배양하여 제1항 내지 제23항중 어느 한항의 폴리펩티드를 제조하는 방법.A method of preparing a polypeptide of any one of claims 1 to 23 by culturing the microorganism of claim 29. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019930009915A 1993-06-02 1993-06-02 Nucleotide sequence and amino acid sequence of hcv hypervariable region KR100301795B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019930009915A KR100301795B1 (en) 1993-06-02 1993-06-02 Nucleotide sequence and amino acid sequence of hcv hypervariable region

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019930009915A KR100301795B1 (en) 1993-06-02 1993-06-02 Nucleotide sequence and amino acid sequence of hcv hypervariable region

Publications (2)

Publication Number Publication Date
KR950000882A true KR950000882A (en) 1995-01-03
KR100301795B1 KR100301795B1 (en) 2001-10-22

Family

ID=37529178

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930009915A KR100301795B1 (en) 1993-06-02 1993-06-02 Nucleotide sequence and amino acid sequence of hcv hypervariable region

Country Status (1)

Country Link
KR (1) KR100301795B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970010787A (en) * 1995-08-14 1997-03-27 성재갑 Fusion protein comprising hepatitis B virus surface antigen and hepatitis C virus envelope protein and mixed vaccine comprising the same

Also Published As

Publication number Publication date
KR100301795B1 (en) 2001-10-22

Similar Documents

Publication Publication Date Title
AU8700291A (en) Hcv-specific peptides, agents therefor and the use thereof
KR960704038A (en) Cytokines That Bind the Cell Surface Receptor Hek
ATE551423T1 (en) SEQUENCES OF HEPATITIS C VIRUS GENOTYPES AND THEIR USES AS THERAPEUTICS AND DIAGNOSTICS
DK0489968T3 (en) Synthetic antigens for detection of antibodies against hepatitis C virus
ATE135403T1 (en) PREPARATION AND PURIFICATION OF A PROTEIN FUSIONED WITH A BINDING PROTEIN
NZ502391A (en) Mammalian cytokine: interleukin-B30 and related reagents
ATE171710T1 (en) HCV PEPTIDE ANTIGENS AND METHODS FOR DETERMINING HCV
ATE153031T1 (en) PEPTIDE FOR STIMULATING CYTOTOIC T LYMPHOCYTES SPECIFIC TO HEPATITIS C VIRUS
KR850006550A (en) Protein manufacturing method
KR930700657A (en) Novel T-cell Lymphoma cDNA Clone
BR0309401A (en) isolated polynucleotide, expression vector, cultured cell, method for producing polypeptides, and an antibody to a polypeptide, and, antibody
KR950000882A (en) Nucleotide and Amino Acid Sequences of the Hypervariable Region of Korean Hepatitis C Virus
Strong et al. Amino acid sequence studies on the. alpha. chain of human fibrinogen. Complete sequence of the largest cyanogen bromide fragment
DK0794255T3 (en) Method for cleavage of chimeric protein using processing enzyme
KR920703640A (en) Non-A Hepatitis B Virus Antigen Protein
DE3853693D1 (en) TBE virus western subtype DNA and RNA molecules, polypeptides encoded by these molecules, and their use.
Wellner et al. N-terminal amino acid sequences of the hemopexins from chicken, rat and rabbit
KR950000880A (en) Total Nucleotide Sequences and Amino Acid Sequences Inferred from KHCV-L2, a Type of Korean Hepatitis C Virus
ES2170051T3 (en) PROCEDURE FOR THE PRODUCTION OF PROTEINS USING FUSIONED PROTEINS OF TYPE CKS.
KR950000881A (en) Nucleotide Sequences and Amino Acid Sequences Inferred from the New Korean Hepatitis C Virus CDD
DK1551867T3 (en) Use of poly-alpha-2,8-sialic acid mimetic peptides for modulating NCAM functions
BR0204599A (en) Hcv core protein sequences
SG145521A1 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus
SE9101740D0 (en) NEW DNA FRAGMENTS AND SEQUENCES
NO950527L (en) Analogous Procedure for Preparation of Non-A, Non-B Hepatitis Virus Antigen Peptide

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20040324

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee